Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic.
Delaloge S, Bonastre J, Borget I, Garbay JR, Fontenay R, Boinon D, Saghatchian M, Mathieu MC, Mazouni C, Rivera S, Uzan C, André F, Dromain C, Boyer B, Pistilli B, Azoulay S, Rimareix F, Bayou el-H, Sarfati B, Caron H, Ghouadni A, Leymarie N, Canale S, Mons M, Arfi-Rouche J, Arnedos M, Suciu V, Vielh P, Balleyguier C. Delaloge S, et al. Among authors: saghatchian m. Eur J Cancer. 2016 Oct;66:131-7. doi: 10.1016/j.ejca.2016.06.021. Epub 2016 Aug 26. Eur J Cancer. 2016. PMID: 27569041
[Molecular signatures of breast cancer: What clinical utility?].
Delaloge S, Saghatchian M, Ghouadni A, Fekih M, André F. Delaloge S, et al. Among authors: saghatchian m. Bull Cancer. 2015 Jun;102(6 Suppl 1):S102-5. doi: 10.1016/S0007-4551(15)31227-3. Bull Cancer. 2015. PMID: 26118866 French.
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status.
Giacchetti S, Hamy AS, Delaloge S, Brain E, Berger F, Sigal-Zafrani B, Mathieu MC, Bertheau P, Guinebretière JM, Saghatchian M, Lerebours F, Mazouni C, Tembo O, Espié M, Reyal F, Marty M, Asselain B, Pierga JY. Giacchetti S, et al. Among authors: saghatchian m. Eur J Cancer. 2017 Apr;75:323-332. doi: 10.1016/j.ejca.2017.01.008. Epub 2017 Mar 7. Eur J Cancer. 2017. PMID: 28279941 Clinical Trial.
Reply to V.P. Retèl et al, D. Gauchan et al, and C. Rahilly-Tierney et al.
Bonastre J, Marguet S, Lueza B, Michiels S, Delaloge S, Saghatchian M. Bonastre J, et al. Among authors: saghatchian m. J Clin Oncol. 2015 May 10;33(14):1629-30. doi: 10.1200/JCO.2014.60.5568. Epub 2015 Apr 6. J Clin Oncol. 2015. PMID: 25847933 No abstract available.
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Bizot A, Karimi M, Rassy E, Heudel PE, Levy C, Vanlemmens L, Uzan C, Deluche E, Genet D, Saghatchian M, Giacchetti S, Grenier J, Patsouris A, Dieras V, Pierga JY, Petit T, Ladoire S, Jacot W, Benderra MA, De Jesus A, Delaloge S, Lambertini M, Pistilli B. Bizot A, et al. Among authors: saghatchian m. Br J Cancer. 2021 Nov;125(11):1486-1493. doi: 10.1038/s41416-021-01555-y. Epub 2021 Sep 29. Br J Cancer. 2021. PMID: 34588616 Free PMC article.
64 results